Your browser doesn't support javascript.
loading
Clinical translational barriers against nanoparticle-based imaging agents.
Jin, Rongrong; Fu, Xiaomin; Pu, Yiyao; Fu, Shengxiang; Liang, Hong; Yang, Li; Nie, Yu; Ai, Hua.
Afiliação
  • Jin R; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • Fu X; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • Pu Y; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • Fu S; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • Liang H; Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China; Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of
  • Yang L; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
  • Nie Y; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Electronic address: nie_yu@scu.edu.cn.
  • Ai H; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China; Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: huaai@scu.edu.cn.
Adv Drug Deliv Rev ; 191: 114587, 2022 12.
Article em En | MEDLINE | ID: mdl-36309148

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Holanda